Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Moodys
McKinsey

Last Updated: June 25, 2022

Glenmark Pharms Ltd Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has seventy-seven approved drugs.

There are seven tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for Glenmark Pharms Ltd
US Patents:0
Tradenames:65
Ingredients:62
NDAs:77

Drugs and US Patents for Glenmark Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Ltd EZETIMIBE ezetimibe TABLET;ORAL 078560-001 Jun 26, 2015 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Pharms Ltd RANOLAZINE ranolazine TABLET, EXTENDED RELEASE;ORAL 211082-001 Jul 5, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Pharms Ltd FLUOCINONIDE ACETONIDE fluocinolone acetonide OIL;TOPICAL 210539-001 Oct 26, 2018 AT RX No No See Plans and Pricing See Plans and Pricing
Glenmark Pharms Ltd TOPIRAMATE topiramate CAPSULE, EXTENDED RELEASE;ORAL 210278-003 Feb 1, 2021 AB2 RX No No See Plans and Pricing See Plans and Pricing
Glenmark Pharms Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 201914-002 Jul 1, 2013 AB RX No No See Plans and Pricing See Plans and Pricing
Glenmark Pharms Ltd ADAPALENE AND BENZOYL PEROXIDE adapalene; benzoyl peroxide GEL;TOPICAL 208108-001 Nov 8, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
AstraZeneca
McKinsey
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.